Physician

Robert S Lavey, MD

According to 2025 Medicare claims, Robert Lavey, MD (NPI: 1932209855) practices radiation oncology in the Lexington-Fayette, KY market, with the plurality of this provider's patient population coming from Fayette, KY. This provider's primary affiliated billing organization is LEXINGTON RADIATION THERAPY CENTER, P.S.C. (NPI: 1255426334; TIN: 61-1091600) and primary practice location at 40504-3746. Lavey is affiliated with the CHI Saint Joseph Health Partners (ACO ID: A4638) and Senior Health Connect ACO 10 (ACO ID: A5386), participating under the MSSP model.

Lavey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 165 traditional Medicare patients, billed 2,789 HCPCS/CPT codes, and received $556,499 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 600 prescription claims across 165 beneficiaries totaling $13,080 in drug costs, led by Oxybutynin Chloride Er (Oxybutynin Chloride). 2022 DME data shows 28 claims. Open Payments data shows 3 records totaling $142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $104,730 and ending at $556,499. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,802 and ending at $13,080. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	70	1,726	$104,730
2016	96	1,882	$114,461
2017	101	1,728	$104,503
2018	142	699	$106,855
2019	592	17,523	$5,952,418
2020	730	23,279	$8,060,160
2021	795	15,104	$5,572,446
2022	231	2,527	$696,212
2023	140	2,052	$408,232
2024	165	2,789	$556,499

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	116	$3,802
2016	38	122	$3,448
2017	38	139	$3,849
2018	22	77	$2,216
2019	137	333	$10,484
2020	166	479	$24,215
2021	167	436	$14,055
2022	125	261	$11,059
2023	97	317	$8,811
2024	165	600	$13,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	28	$3,035
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	55	622	$244
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	63	63	$156
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	107	$86
77014	Ct guidance for insertion of radiation therapy fields	65	648	$83
77336	Continuing radiation therapy consultation per week	60	193	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxybutynin Chloride Er	Oxybutynin Chloride	96	8,280	$2,830
Tamsulosin Hcl	Tamsulosin Hcl	178	15,704	$2,745
Ondansetron Hcl	Ondansetron Hcl	18	229	$407
Dexamethasone	Dexamethasone	66	187	$268
Finasteride	Finasteride	17	1,170	$135

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$142	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert S. Lavey, MD?

Tedicare shows public-source Medicare data for Robert S. Lavey, MD (NPI 1932209855), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert S. Lavey, MD have ACO affiliation data?

Robert S. Lavey, MD is shown with ACO affiliation data for CHI Saint Joseph Health Partners (MSSP, ACO ID A4638) and Senior Health Connect ACO 10 (MSSP, ACO ID A5386).

What billing organization is linked to Robert S. Lavey, MD?

Robert S. Lavey, MD is linked to LEXINGTON RADIATION THERAPY CENTER, P.S.C. (billing NPI 1255426334) in the available physician profile data.

Does Robert S. Lavey, MD have Open Payments data?

Robert S. Lavey, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.